Statin initiation by GPs in WA: A structured vignette study

Australian Family Physician

Volumn 38, Issue 9, 2009, Pages 739-742

  Stafford, Leanne ^a   Harmer, Nichola ^a   Dhaliwal, Satvinder ^a   Jiwa, Moyez ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; AUSTRALIA; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; PRACTICE GUIDELINE; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; WESTERN AUSTRALIA;

EID: 74049160356     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand. Reducing risk in heart disease 2007. Available at www.heartfoundation. org.au/Professional_Information/Clinical_Practice/CHD/Pages/default.aspx [Accessed 2 June 2008].
2. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
3. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002;360:7-22.
4. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002;360:1623-30.
5. de Lemos JA, Blazing MA, Wiviott SD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: Phase Z of the A to Z trial. JAMA 2004;292:1307-16.
6. Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: A randomized controlled trial. JAMA 2001;285:1711-8.
7. Chew DP, Amerena J, Coverdale S, Rankin J, Astley C, Brieger D. Current management of acute coronary syndromes in Australia: Observations from the acute coronary syndromes prospective audit. Int Med J 2007;37:741-8.
8. Bailey TC, Noirot LA, Blickensderfer A, et al. An intervention to improve secondary prevention of coronary heart disease. Arch Intern Med 2007;167:586-90.
9. Vasaiwala S, Nolan E, Ramanath VS, et al. A quality guarantee in acute coronary syndromes: The American College of Cardiology's Guidelines Applied in Practice program taken real-time. Am Heart J 2007;153:16-21.
10. Stocks NP, Ryan P, McElroy H, et al. Statin prescribing in Australia: Socioeconomic and sex differences. Med J Aust 2004;180:229-31.
11. Kirwan JR, Chaput de Saintonge DM, Joyce CR. Clinical judgment analysis. Q J Med 1990;76:935-49.
12. Structured interview and questionnaire surveys. In: Burns RB. Introduction to research methods. 4th edn. Thousand Oaks: Sage Publications; 2000 p. 566-93.
13. Babbie E. Survey research in the practice of social science. Belmont: Wadsworth Publishing, 1996.
14. SPSS for Windows [computer software]. Release 15.0.0 Chicago: SPSS Inc; 6 Sep 2006.
15. Britt H, Miller GC, Charles J, et al. General practice activity in Australia 2006-07. General practice series no. 21. Cat. no. GEP 21. Canberra: Australian Institute of Health and Welfare, 2008.
16. Primary Health Care Research & Information Service. Key division of general practice characteristics 2006-2007 [online] 2008. Available at www.phcris.org.au/products/asd/keycharacteristic/KeyDGPstatistics.xls [Accessed 2 June 2008].
17. Drane JW, Richter D, Stoskopf C. Improved imputation of non-responses to mailback questionnaires. Stat Med 1993;12:283-8.
18. DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994-2001: A case of agism but not of sexism? Heart 2003;89:417-21.
19. Byrne M, Murphy AW, Walsh JC, Shryane E, McGroarty M, Kelleher CC. A crosssectional study of secondary cardiac care in general practice: Impact of personal and practice characteristics. Fam Pract 2006;23:295-302.
20. Ashworth M, Lloyd D, Smith RS, Rowlands G. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and outcomes framework'. J Pub Health 2007;29:40-7.
21. Yang C, Jick SS, Testa MA. Who receives lipid-lowering drugs: The effects of comorbidities and patient characteristics on treatment initiation. Br J Clin Pharmacol 2003;55:288-98.
22. Simpson CR, Hannaford PC, Williams D. Evidence for inequalities in the management of coronary heart disease in Scotland. Heart 2005;91:630-4.
23. Milder IE, Blokstra A, de Groot J, van Dulmen S, Bemelmans WJ. Lifestyle counseling in hypertension-related visits - analysis of video-taped general practice visits. BMC Fam Pract 2008;9:58.
24. Mantel-Teeuwisse AK, Klungel OH, Schalekamp T, Verschuren WMM, Porsius AJ, de Boer A. Suboptimal choices and dosing of statins at start of therapy. Br J Clin Pharmacol 2005;60:83-9.
25. Hickling J, Rogers S, Nazareth I. Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: Primary care perceptions. Br J Gen Pract 2005;55:534-8.
26. Kedward J, Dakin L. A qualitative study of barriers to the use of statins and the implementation of coronary heart disease prevention in primary care. Br J Gen Pract 2003;53:684-9.
27. Emberson JR, Whincup PH, Lawlor DA, Montaner D, Ebrahim S. Coronary heart disease prevention in clinical practice: Are patients with diabetes special? Evidence from two studies of older men and women. Heart 2005;91:451-5.